SEC Filing Update: #CLRB Cellectar Biosciences, Inc. : $2.59

Sector: Healthcare | YTD: 🔽 -25.36% The SEC disclosed Today (14-AUG-2026) that SILVERARC CAPITAL MANAGEMENT, LLC has INCREASED #CLRB Shares by 164.60% 🟢 StemPoint Capital LP also reported an increase in its holdings on the same day. BALYASNY ASSET MANAGEMENT LLC also newly bought shares on the same day. * Previous Holdings: 321.73K Shares * Current Holdings: 851.28K Shares * Increase+529.56K * Increased(%)+164.60% * Ownership: 9.99% * Estimated Investment Value: $1.36M https://www.thinksabio.com/reports/isr/CLRB 📌 Institutional activity in the last 30 days for #CLRB: • EMPERY ASSET MANAGEMENT, LP – Newly bought 864,090 shares (04-AUG-2026) • BLEICHROEDER LP – Increased holdings by 519,621 shares (13-AUG-2026) • StemPoint Capital LP – Increased holdings by 490,802 shares (14-AUG-2026) • BALYASNY ASSET MANAGEMENT LLC – Newly bought 798,382 shares (14-AUG-2026)